EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury

Shan Tang, Xiaodan Zhang, Zhongping Duan, Manman Xu, Ming Kong, Sujun Zheng, Li Bai, Yu Chen

International Immunopharmacology · 2023-03 · 116 · 109808

DOI: 10.1016/j.intimp.2023.109808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-03. Verfasst von Shan Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Artificial Liver Center, Beijing YouAn Hospital, Capital M…. Hauptthemen laut MEDLINE: Liver Diseases, MicroRNAs, Silybin. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Silibinin-phospholipid complex (SPC) has been utilized to treat acute liver injury clinically. Nevertheless, the hepatoprotective mechanism of SPC remains to be further dissected in response to new insights into the pathogenesis of acute liver injury. Very recently, we have documented, for the first time, that M2-like macrophages exert the hepatoprotection against acute insult through inhibiting necroptosis-S100A9-necroinflammation. In the present work, we integrated this new finding into the mechanism of action of SPC, and attempted to dissect the hepatoprotective mechanism of SPC from this new perspective. METHODS: SPC and corresponding controls were administered intragastrically into control mice subjected to d-GalN/LPS challenge. The hepatic damage was assessed, and the expression of necroptosis-S100A9-necroinflammation signaling molecules was detected. The correlation between SPC and macrophage activation was investigated. The expression of miR-223-3p and its regulation on macrophage activation were analyzed. The targeted inhibitory effects of miR-223-3p on necroptosis and necroinflammation signaling molecules were confirmed. RESULTS: SPC alleviated remarkably the hepatic damage triggered by d-GalN/LPS. The administration of SPC inhibited the expression of necroptosis-S100A9-necroinflammation signaling molecules. The levels of M2-like macrophage markers were increased significantly in SPC-treated mice or macrophages. miR-223-3p expression was enhanced in SPC-treated mice. miR-223-3p transfer led to up-regulated expression of M2-like macrophage markers. miR-223-3p directly targeted 3' UTR of RIPK3 and NLRP3, and the expression of necroptosis and necroinflammation signaling molecules was inhibited in miR-223-3p-transferred hepatocytes and macrophages. CONCLUSIONS: SPC alleviates acute liver injury through up-regulating the expression of miR-223-3p. MiR-223-3p further promotes M2-like macrophage activation and the targeted inhibition of necroptosis and necroinflammation. Our findings provide novel insight into the hepatoprotective mechanism of SPC against acute liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver DiseasesMicroRNAsSilybinAnimalsMiceLipopolysaccharides

Stichwörter der Autor:innen

Acute liver injuryM2-like macrophagesNecroptosisSilibinin-phospholipid complexmiR-223-3p

Substanzen

LipopolysaccharidesMicroRNAsSilybinMIRN223 microRNA, mouse

Autor:innen und Institutionen

  • Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China.
  • Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China. Electronic address: tender7…
  • Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China. Electronic address: chybeyo…

Zitieren

APA

Tang, S., Zhang, X., Duan, Z., Xu, M., Kong, M., Zheng, S., Bai, L., & Chen, Y. (2023). The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury. International Immunopharmacology, 116, 109808. https://doi.org/10.1016/j.intimp.2023.109808

Vancouver

Tang S, Zhang X, Duan Z, Xu M, Kong M, Zheng S, et al. The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury. International Immunopharmacology. 2023;116:109808. doi:10.1016/j.intimp.2023.109808

BibTeX
@article{Tang2023,
  author = {Tang, Shan and Zhang, Xiaodan and Duan, Zhongping and Xu, Manman and Kong, Ming and Zheng, Sujun and Bai, Li and Chen, Yu},
  title = {The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {116},
  pages = {109808},
  doi = {10.1016/j.intimp.2023.109808}
}
Kostenlos starten →